ScholarIQanswers from OpenAlex & ORCID
Eberhard Standl
ResearcherPublications, citations & collaboration network
Eberhard Standl is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Eberhard Standl have?
ScholarIQindexed works
Eberhard Standl has 373 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Eberhard Standl have?
ScholarIQcitation count
Eberhard Standl has 21,428 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Eberhard Standl?
ScholarIQh-index
Eberhard Standl has an h-index of 57 in OpenAlex.
What is the i10-index of Eberhard Standl?
ScholarIQi10-index
Eberhard Standl has an i10-index of 178 in OpenAlex.
What is the ORCID of Eberhard Standl?
ScholarIQorcid
The ORCID for Eberhard Standl is on the source record.
What is the OpenAlex record for Eberhard Standl?
ScholarIQopenalex
The OpenAlex for Eberhard Standl is on the source record.
What are the most-cited papers on Eberhard Standl?
ScholarIQmost cited works
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
John Dormandy, B Charbonnel, D.J.A. Eckland, Erland Erdmann, Massimo Massi‐Benedetti, Ian K. Moules, Allan M. Skene, Meng H. Tan, Pierre J. Lefèbvre, Gordon Murray, Eberhard Standl, Robert G. Wilcox, Lars Wilhelmsen, John Betteridge, Kåre I. Birkeland, Alain Golay, Robert J. Heine, László Korányi, Markku Laakso, Marian Mokáň, Antanas Norkus, Valdis Pīrāgs, Toomas Podar, André Scheen, Werner A. Scherbaum, Guntram Schernthaner, Ole Schmitz, J Skrha, Ulf Smith, J Tatoń
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong, John B. Buse, Samuel S. Engel, Jyotsna Garg, Robert Josse, Keith D. Kaufman, Joerg Koglin, Scott Korn, John M. Lachin, Darren K. McGuire, Michael Pencina, Eberhard Standl, Peter P. Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D. Peterson, Rury R. Holman
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors Task Force Members, L Rydén, Eberhard Standl, M. Bartnik, Greet Van den Berghe, John Betteridge, Menko‐Jan de Boer, Francesco Cosentino, Bengt Jönsson, Markku Laakso, K. Malmberg, Silvia G. Priori, Jan Östergren, J Tuomilehto, Inga S. Þráinsdóttir, Other Contributors, Ilse Vanhorebeek, Marco Stramba‐Badiale, Peter Lindgren, Qing Qiao, Silvia G. Priori, J J Blanc, Andrzej Budaj, A. John Camm, V. Dean, Jaap W. Deckers, Kenneth Dickstein, J. Lekakis, Keith McGregor, Marco Metra, João Morais, A. Osterspey, Juan Tamargo, José Luís Zamorano, Document Reviewers, Jaap W. Deckers, M Bertrand, B Charbonnel, Erland Erdmann, Ele Ferrannini, Allan Flyvbjerg, H. Gohlke, J.R.G. Juanatey, Ian Graham, Pedro Monteiro, Klaus G. Parhofer, Kalevi Pyörälà, Itamar Raz, Guntram Schernthaner, Massimo Volpe, David M. Wood
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan, Jean‐Louis Chiasson, Huimei Feng, Junbo Ge, Hertzel C. Gerstein, Richard Gray, Yong Huo, Zhihui Lang, John J.V. McMurray, Lars Rydén, Stefan Schröder, Yihong Sun, Michael J. Theodorakis, Michał Tendera, Lynne Tucker, Jaakko Tuomilehto, Yidong Wei, Wenying Yang, Duolao Wang, Dayi Hu, Changyu Pan, Joanne F. Keenan, Joanne Milton, Zoë Doran, Chris Bray, Jean L. Rouleau, Jane Collier, Stuart Pocock, Eberhard Standl, Karl Swedberg, Jianping Weng, Dong Zhao, Mark C. Petrie, Eugene Connolly, Pardeep S. Jhund, Michael R. MacDonald, Rachel C. Myles, Rong Bai, Jing Li, Zhaoping Liu, Zhenyu Liu, Dantao Peng, Tong Qiguang, Chunxue Wang, Xiaowei Yan, Yuqing Zhang, Jingmin Zhou, Naveed Sattar, Miles Fisher, John R. Petrie, M. Angelyn Bethel, Wen Xu, Sarah Hearn, Anurag Kappai, Shu-Yi Su, Winitha Liyanage, Sanjoy K. Paul, Emanuela Pozzi, Arne Ring, Rajbir Athwal, Priyanka Batra, Andrea Ferch, Natasha Groves, Irene Kennedy, Olga Nawalaniec, Yash Patel, Rachel Roberts, Victoria Rush, Jayne Starrett, Jennifer Tang, Jing Bi, Zhe Jiang, Hua Wei, Xiaoshuai Wei, Xuan Zhang, Jun Yin, Yu Sun, Rong Hu, Yang Liu, Jianjing Long, Yuefeng Long, Guofang Qiao, Haoyi Qiao, Xiaochun Sun, Yucheng Zhang, Jing Zhou, Bangning Wang, Bin Chen, Lili Deng, Xiaoning Han, Taohong Hu, Qi Hua, Yanming Huo, Hongmei Li, Hongwei Li, Lihua Liu, Juming Lu, Changsheng Ma
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi, Kailei Nong, Per Olav Vandvik, Gordon Guyatt, Oliver Schnell, Lars Rydén, Nikolaus Marx, Frank C. Brosius, Reem A. Mustafa, Arnav Agarwal, Xinyu Zou, Yunhe Mao, Aminreza Asadollahifar, Saifur Rahman Chowdhury, Chunjuan Zhai, Sana Gupta, Ya Gao, João Pedro Lima, Kenji Numata, Zhi Qiao, Qinlin Fan, Qinbo Yang, Yinghui Jin, Long Ge, Qiuyu Yang, Hongfei Zhu, Fan Yang, Zhe Chen, Xi Lü, Siyu He, Xiangyang Chen, Xiafei Lyu, Xingxing An, Yaolong Chen, Qiukui Hao, Eberhard Standl, Reed Siemieniuk, Thomas Agoritsas, Haoming Tian, Sheyu Li